Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 350, Issue 6, pp 646–652 | Cite as

Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency

  • M. Hropot
  • H. Grötsch
  • E. Klaus
  • K. H. Langer
  • W. Linz
  • G. Wiemer
  • B. A. Schölkens
Original Articles
Received:
Accepted:

Abstract

Inhibition of the angiotensin converting enzyme (ACE) with ramipril was studied in male Wistar rats during long-term inhibition of nitric oxide (NO) synthase by NG-nitro-l-arginine methyl ester (l-NAME). Chronic treatment with l-NAME in a dose of 25 mg/kg per day over 6 weeks caused myocardial hypertrophy and a significant increase in systolic blood pressure (245 ± 16 mmHg) as compared to controls (155+4 mmHg). Animals receiving simultaneously l-NAME and ramipril were protected against blood pressure increase and partially against myocardial hypertrophy. L-NAME caused a significant reduction in glomerular filtration rate (GFR: 2.56+0.73 ml·kg−1·min−1) and renal plasma flow (RPF: 6.93±1.70ml·kg−1·min−1) as compared to control (GFR: 7.29±0.69, RPF: 21.36±2.33ml·kg−1·min−1). Addition of ramipril prevented l-NAME-induced reduction in GFR and renal plasma flow. l-NAME produced an elevation in urinary protein excretion and serum creatinine and a decrease in potassium excretion which was antagonised by ramipril. L-NAME-induced increase in plasma renin activity (PRA) was further elevated with ramipril treatment. Isolated hearts from rats treated with l-NAME showed increased post-ischaemic reperfusion injuries. Compared to controls duration of ventricular fibrillation was increased and coronary flow reduced. During ischaemia the cytosolic enzymes lactate dehydrogenase and creatine kinase, as well as lactate in the venous effluent were increased. Myocardial tissue values of glycogen, ATP, and creatine phosphate were decreased, whereas lactate was increased. Coadministration of ramipril reversed these effects. l-NAME treatment reduced the cyclic GMP content in urine and renal arteries, and was not changed by additional ramipril-treatment. In the kidney hyalinosis of arterioles and of glomerular capillaries, as well as mesangial expansion and tubular atrophies seen after long-term inhibition of NO synthase were reduced by coadministration of ramipril. In conclusion, long-term ACE inhibition by ramipril prevented l-NAME-induced hypertension and cardiac hypertrophy, and attenuated functional and morphological changes in the kidneys. In addition, cardiac-dynamic and -metabolic deterioration induced by L-NAME was normalised by co-treatment with ramipril.

Key words

Nitric oxide NG-nitro-L-arginine methyl ester Kidney Heart Hypertension Renal haemodynamics Renin-angiotensin system Rat 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arnal J-F, Warin L, Michel J-B (1992) Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 90:647–652Google Scholar
  2. Bartels H, Bohmer M, Heierli C (1972) Serum Kreatininbestimmung ohne Enteiweissen. Clin Chim Acta 37:193–197Google Scholar
  3. Baylis Ch, Mitruka B, Deng A (1992) Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90:278–281Google Scholar
  4. Becker RHA, Wiemer G, Linz W (1991) Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol [Suppl 2] 18:S110-S115Google Scholar
  5. Bonin P (1897) Etudes sur l'évolution normale et l'involution du tube seminifère. Arch d'Anat Mier 1:225–339Google Scholar
  6. El karib AO, Sheng J, Betz AL, Malvin RL (1993) The central effects of a nitric oxide synthase inhibitor (Nω-nitro-l-arginine) on blood pressure and plasma renin. Clin Exp Hypertens 15(5):819–832Google Scholar
  7. Förstermann U, Mülsch A, Bohme E, Busse R (1986) Stimulation of soluble guanilate cyclase by an acetylcholine-induced endotheliumderived factor from rabbit and canine arteries. Circ Res 58:531–538Google Scholar
  8. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376PubMedGoogle Scholar
  9. Gardiner Sheila M, Compton AM, Bennett T, Palmer RMJ, Moncada S (1990) Control of regional blood flow by endothelium-derived nitric oxide. Hypertens 15:486–492Google Scholar
  10. Hackenthal E, Paul M, Ganten D, Taugner R (1990) Morphology, physiology and molecular biology of renin secretion. Physiol Rev 70: 1067–1116Google Scholar
  11. Katsuki S, Arnold W Mittal C, Murad F (1977) Stimulation of guanilate-cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cycl Nucleot Res 3:23–35Google Scholar
  12. Linz W, Schölkens BA, Han YF (1986) Beneficial effects of the converting enzyme inhibitor ramipril in ischaemic rat hearts. J Cardiovasc Pharmacol [Suppl 10] 8:591-S99Google Scholar
  13. Linz W, Wiemer G, Scholkens BA (1992) ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. J Mol Cell Cardiol 24:909–919Google Scholar
  14. Liu SF, Crawley DE, Rohde JAL, Evans TW Barnes PJ (1992) Role of nitric oxide and guanosine 3′,5′-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries. Br J Pharmacol 107:861–866Google Scholar
  15. Morton JJ, Beattie EC, Speirs A, Gulliver F (1993) Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J Hypertens 11:1083–1088Google Scholar
  16. Naess PA, Christensen G, Kirkebøen KA, Kiil F (1993) Effect on renin release of inhibiting renal nitric oxide synthesis in anaesthetized dogs. Acta Physiol Scand 148:137–142Google Scholar
  17. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526CrossRefPubMedGoogle Scholar
  18. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ (1993) Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21:660–666Google Scholar
  19. Rees DD, Palmer RMJ, Moncada S (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci 86:3375–3378PubMedGoogle Scholar
  20. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R (1992) Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20:298–303Google Scholar
  21. Salazar FJ, Pinilla JM, López F, Romero JC, Quesade T (1992) Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 20:113–117Google Scholar
  22. Schelling P, Fischer H, Ganten D (1991) Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 9:3–15Google Scholar
  23. Schricker K, Kurtz A (1993) Liberators of NO exert a dual effect on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol 34:F180-F186Google Scholar
  24. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Gräber M (1945) The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 24:288–293Google Scholar
  25. Toda N, Okamura T (1992) Mechanism of neurally induced monkey mesenteric artery relaxation and contraction. Hypertens 19:161–166Google Scholar
  26. Toda N, Kitamura Y, Okamura T (1993) Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension 21:3–8Google Scholar
  27. Togashi H, Sakuma I, Yishioka M, Kobayashi T, Yasuga H, Kitabatake A, Saito H, Gross SS, Levi R (1992) A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 262:343–347Google Scholar
  28. Tresham JJ, Dusting GJ, Coghlan JP, Whitworth JA (1991) Haemodynamic and hormonal effects of N-nitro-L-arginine, an inhibitor of nitric oxide biosynthesis, in sheep. Clin Exp Pharmacol Physiol 18:327–330Google Scholar
  29. Walser M, Douglas G, Davidson G, Orloff J (1955) The renal clearance of alkali-stable inulin. J Clin Invest 34:1520–1523Google Scholar
  30. Wiemer G, Scholkens BA, Becker RHA, Busse R (1991) Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 18:558–563Google Scholar
  31. Wiemer G, Schölkens BA, Linz W (1994) Endothelial protection by converting enzyme inhibitors. Cardiovasc Res 28:166–172Google Scholar
  32. Wilcox ChS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HHHW (1992) Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Nall Acad Sci 88:11993–11997Google Scholar
  33. Zatz R, de Nucci G (1991) Effects of acute nitric oxide inhibition of rat glomerular microcirculation. Am J Physiol 30:F360-F363Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • M. Hropot
    • 1
  • H. Grötsch
    • 1
  • E. Klaus
    • 1
  • K. H. Langer
    • 1
  • W. Linz
    • 1
  • G. Wiemer
    • 1
  • B. A. Schölkens
    • 1
  1. 1.Hoechst AG, SBU Cardiovascular AgentsFrankfurt am MainGermany

Personalised recommendations